- Profile
- Personal Information
- Publications
Experts in Social and Political Sciences
Hugh Elton Felix Racine Laure Dubreuil Rodney Fitzsimons Helen Haines Sharon Hepburn Gyles Iannone Anne Keenleyside Paul Manning Anne Meneley LAM Hon Ming Abhay Kumar Dubey Dr. Reinhard Achenbach Dr. Suman negi Dr. Nirmal Selvamony Dr. Rainer Albertz Dr, N.K Nohanty Dr. T. J. Abraham Dr. P Geetha Rani Dr, S.M.I.A. Zaidi View MoreDavid was appointed Chief Strategy Officer of GSK in May 2008 and is responsible for corporate development and strategic planning. During the last six years GSK has entered into numerous bolt-on acquisitions and joint ventures including, in particular, a multi-billion dollar three-way asset swap with Novartis. He is a member of the Corporate Executive Team and reports to the CEO, Sir Andrew Witty. Previously, he was responsible for the leadership of GSK’s business in Northern Europe from 2005 to 2008 and Central and Eastern Europe from 2002 to 2005. He joined Glaxo in 1994 in finance
David was appointed Chief Strategy Officer of GSK in May 2008 and is responsible for corporate development and strategic planning. During the last six years GSK has entered into numerous bolt-on acquisitions and joint ventures including, in particular, a multi-billion dollar three-way asset swap with Novartis. He is a member of the Corporate Executive Team and reports to the CEO, Sir Andrew Witty. Previously, he was responsible for the leadership of GSK’s business in Northern Europe from 2005 to 2008 and Central and Eastern Europe from 2002 to 2005. He joined Glaxo in 1994 in finance